2024
Progesterone receptor status predicts aggressiveness of human endometriotic lesions in murine avatars
Flores V, Sahin C, Taylor H. Progesterone receptor status predicts aggressiveness of human endometriotic lesions in murine avatars. F&S Science 2024, 6: 65-72. PMID: 39393571, DOI: 10.1016/j.xfss.2024.10.004.Peer-Reviewed Original ResearchProgestin-based therapyAggressive forms of endometriosisPR lesionsProgesterone receptorGnRH antagonistMedroxyprogesterone acetatePR statusEndometriotic lesionsAggressive formResponse to MPAResponse to medical therapyPost-treatment sizeProgesterone receptor statusHuman endometriotic lesionsResponse to progestinsChronic gynecological diseaseDaily subcutaneous injectionsReproductive-age womenMouse xenograft modelResponse to medicationEndometrioma lesionsReceptor statusHormone suppressionPR expressionClinical response
2023
Does Coronary Plaque Morphology Matter Beyond Plaque Burden?
Lorenzatti D, Piña P, Csecs I, Schenone A, Gongora C, Garcia M, Blaha M, Budoff M, Williams M, Dey D, Berman D, Virani S, Slipczuk L. Does Coronary Plaque Morphology Matter Beyond Plaque Burden? Current Atherosclerosis Reports 2023, 25: 167-180. PMID: 36808390, DOI: 10.1007/s11883-023-01088-0.Peer-Reviewed Original ResearchConceptsCoronary Computed Tomography AngiographyMedical therapyPlaque burdenResponse to medical therapyPlaque analysisCoronary plaquesAssessment of coronary plaquesHigh-risk phenotypePreventive medical therapyAdverse cardiovascular eventsCoronary plaque featuresRandomized Controlled TrialsPericoronary inflammationMyocardial infarction typeCardiovascular eventsDisease progressionRisk phenotypesCulprit plaquesControlled TrialsPlaque characteristicsPlaque featuresTherapySummaryThe identificationTracking disease progressionInfarct type
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply